(Date:11/30/2009)...avily more often than younger people, study finds,...- Older people who are problem drinkers consume mo...report finds, possibly because they need more alco... a study released this month, people dependent on ... drinks a week, on average. By contrast, younger a...
(Date:11/30/2009).... Rappa, MD, explores the intricate connection bet...ealing Heart to Soul: One Doctor’s Journey o...9). , Dallas, TX (Vocus) ... let go of negative emotions, whether caused by us...oulders. Oftentimes, this disease of the human spi...
(Date:11/30/2009)..., Nov. 30 Baxa Corporation is spon... "culture of safety" means in today,s pharmacy env...eating a Culture of Safety in Pharmacy ," features... their experiences with culture of safety, what it...d the role of technology in enabling or inhibiting...
(Date:11/30/2009)...v. 30 EMD Serono, an affiliate of ...at it received a refuse to file letter from the US...g Application (NDA) for Cladribine Tablets, EMD Se...n of cladribine, as a therapy for relapsing forms ...ll work closely with the FDA to fully understand F...
(Date:11/30/2009)... A new study has found that 27% of...rance customers have a current intention to shop f...he figure is up from 20% in 2008. Over the past f...een a leading indicator of actual switching patter...itch actually will leave their current insurer for...
Breaking Medicine News(10 mins):Health News:Binge Drinking Not Just a Rite of the Young 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 2Health News:EMD Serono Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application 3Health News:More Seniors Considering Health Insurance Switch 2...Corporation,(NYSE: SYK ) announced that it will h...7 at 4:30 p.m., Eastern Time, to discuss the Compa...mber 30, 2007 and provide an,operational update. O...Officer, Dean H.,Bergy, Vice President and Chief F...
...ncourages carcinogens, study suggests , THURSDAY, ... the stomach, vitamin C transforms from a cancer-f...w research suggests. , Researchers at Western Infi...ancerous changes and tumor growth. They focused o...
... Vall d,Hebron Hospital have diagnosed two patient...es coughing and difficulty in breathing due to irr...ce. Until now, medical literature had only describ...haling. Under normal conditions, the vocal cords w...
... briefs from,HealthFitness (OTC Bulletin Board: HF...evolving into employer partners to create a cultur...in/prnh/20070830/HFLOGO ) "Corporate America Emb...to address the high cost of health care,in a globa...
... Merger; Says ,Shareholders Have Already ...re, NEW YORK, Sept. 6 Elliott Associates, L.P.,(...jor shareholder of,Bioenvision (Nasdaq: BIVN ), t...e, 41st Floor New York, NY 10154, Dear Members ...
... Kris Carr is a photographer, director, produce... (TLC) documentary film "Crazy Sexy Can...er Tips." In 2003 Carr was diagnosed wi...rr became determined to find answers wh...
Other Medicine News:Health News:Stryker To Host Conference Call on October 17, 2007 2Health News:Vitamin C Plus Fat Might Spur Cancer 2Health News:Vocal cord dysfunction may be caused by work 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 2Health News:HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 2Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 3Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 4Health News:Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company 5Health News:Author Kris Carr to Sign 'Crazy Sexy Cancer Tips' at Two Borders(R) Stores in California 2(Date:11/30/2009)... , WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewsw...Annual Meeting of the Radiological Society of No...ls Inc. announced the enrollment of the first pati...o evaluate the efficacy and safety of florbetaben ...-Amyloid plaques in the brain, which are a patholo...
(Date:11/30/2009)... , RICHMOND, Va., Nov. 30 I...nse with sanofi-aventis U.S. for a novel epinephri.... Under the license, sanofi-aventis U.S. shall be ...n. Intelliject will be responsible for the on-goin...proval and has retained certain co-promotion right...
(Date:11/30/2009)... , CHICAGO, Nov. 30 /PRNewswire-USNewswire/ -...isk ,, A new study from Cincinnati Children,s ...stay-tabs pose a potential ingestion risk. In the ... design after safety concerns about pull-tabs. The... a single institution, mainly among teenagers. Fur...
Breaking Medicine Technology:Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Despite Managed Care Obstacles Interest and Anticipated Use of Centocor Ortho Biotechs New Psoriasis Agent Stelara 28ustekinumab 29 is High 6544 1Despite Managed Care Obstacles Interest and Anticipated Use of Centocor Ortho Biotechs New Psoriasis Agent Stelara 28ustekinumab 29 is High 6544 2Vanderbilt scientists report first effective medical therapy for rare stomach disorder 62146 1Vanderbilt scientists report first effective medical therapy for rare stomach disorder 62146 2Hormone ghrelin can boost resistance to Parkinsons disease 10903 1Hormone ghrelin can boost resistance to Parkinsons disease 10903 2...ovel siRNA Structures Exhibit Stability and Activi...maceuticals, Inc., a,clinical-stage biopharmaceuti...novel RNA interference-based therapeutics, announc...cation covering a number of novel,chemical modific... and,excellent penetration into the human cells te...
..., Aug. 27 CryoCor, Inc. (Nasdaq:,CRYO), a medical...c,arrhythmias, announced today the completion of e...eatment of atrial fibrillation. Ed Brennan, Ph.D....s a,major milestone for CryoCor, being the first c...tal study for the use of ablation for the treatmen...
Other Medicine Technology:Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules 2Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules 3CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation 2CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation 3Satin-Slip® 10FR Intubating Stylet
Disposable Aluminum 11 1/2" Stylette
Solid Copper Malleable Stylette
S5000N Ultra-Slip™ Stylet
Medicine Products: